Evidence map›Paper›PMID 25932959›Full record

ReviewAmerican journal of respiratory cell and molecular biology2015

Alveolar development and disease.

Jeffrey A Whitsett, Timothy E Weaver

Open access · greenAbstract readReview
In one paragraph

Review in American journal of respiratory cell and molecular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. The Plant Hormone Indole-3-Acetic Acid Helps the Endothelial Barrier Seal after Lung Injury.American journal of respiratory cell and molecular biology · 2024
    Article
  9. Article
  10. Article
  11. Unraveling a Key Molecular Player Governing Pulmonary Alveolar Development.American journal of respiratory cell and molecular biology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jeffrey A WhitsettPerinatal Institute, Divisions of Neonatology, Perinatal and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Timothy E WeaverPerinatal Institute, Divisions of Neonatology, Perinatal and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Cincinnati Children's Hospital Medical Center · US

Funding

SURFACTANT HOMEOSTASIS IN HEALTH AND DISEASEP01HL061646 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI XU, YAN · 1999 to 2008
$14.6M
Structure/Function Analyses Of SP-BR37HL056285 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI WEAVER, TIMOTHY EDWARD · 2001 to 2010
$5.0M
Transcriptional Programming of Asthma Related Pathology in Respiratory EpitheliaR01HL095580 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI WHITSETT, JEFFREY A · 2009 to 2017
$4.7M
"Lung MAP" Atlas Research CenterU01HL122642 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI POTTER, S. STEVEN, WHITSETT, JEFFREY A · 2014 to 2018
$3.9M
Airway Progenitor Cell Profileration and Differentiation During Lung RepairU01HL110964 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI STREETER, PHILIP R, WHITSETT, JEFFREY A · 2012 to 2016
$3.3M
Role of SFTPC in Pathogenesis of Interstitial Lung DiseaseR01HL086492 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI WEAVER, TIMOTHY EDWARD · 2009 to 2013
$2.2M
Transcriptional Control of Submucosal Gland Formation and FunctionR01HL108907 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI WHITSETT, JEFFREY A · 2011 to 2014
$1.6M
Omics of Lung DiseasesK12HL119986 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI WHITSETT, JEFFREY A · 2013 to 2017
$1.3M
NHLBI NIH HHS HL086492NHLBI NIH HHS HL095580NHLBI NIH HHS HL108907NHLBI NIH HHS HL110964NHLBI NIH HHS HL119686NHLBI NIH HHS HL122642NHLBI NIH HHS HL61646NHLBI NIH HHS K12 HL119986NHLBI NIH HHS P01 HL061646NHLBI NIH HHS R01 HL086492NHLBI NIH HHS R01 HL095580NHLBI NIH HHS R01 HL108907NHLBI NIH HHS R37 HL056285NHLBI NIH HHS R37-HL5625NHLBI NIH HHS U01 HL110964NHLBI NIH HHS U01 HL122642
6 · The paper itself

Abstract

Gas exchange after birth is entirely dependent on the remarkable architecture of the alveolus, its formation and function being mediated by the interactions of numerous cell types whose precise positions and activities are controlled by a diversity of signaling and transcriptional networks. In the later stages of gestation, alveolar epithelial cells lining the peripheral lung saccules produce increasing amounts of surfactant lipids and proteins that are secreted into the airspaces at birth. The lack of lung maturation and the associated lack of pulmonary surfactant in preterm infants causes respiratory distress syndrome, a common cause of morbidity and mortality associated with premature birth. At the time of birth, surfactant homeostasis begins to be established by balanced processes involved in surfactant production, storage, secretion, recycling, and catabolism. Insights from physiology and engineering made in the 20th century enabled survival of newborn infants requiring mechanical ventilation for the first time. Thereafter, advances in biochemistry, biophysics, and molecular biology led to an understanding of the pulmonary surfactant system that made possible exogenous surfactant replacement for the treatment of preterm infants. Identification of surfactant proteins, cloning of the genes encoding them, and elucidation of their roles in the regulation of surfactant synthesis, structure, and function have provided increasing understanding of alveolar homeostasis in health and disease. This Perspective seeks to consider developmental aspects of the pulmonary surfactant system and its importance in the pathogenesis of acute and chronic lung diseases related to alveolar homeostasis.

Indexed as

HomeostasisPulmonary AlveoliHumansInfant, NewbornInfant, PrematurePulmonary SurfactantsRespiration, ArtificialRespiratory Distress Syndrome, NewbornPulmonary Surfactantslung developmentmaturationpulmonarysurfactant

Identifiers

PMID25932959
PMCPMC4566117
OpenAlexW2061210530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.